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A  RAPID, simple and low-cost assay method of hista-
mine-N-methyltransferase  activity  was  developed.
Methylhistamine,  which  was  separated  from  the
enzymatic  reaction  system  on reversed-phase high-
performance  liquid  chromatography  using  an  ion-
paired  chromatographic  technique,  was  detected
spectrophotometrically at 226nm. The mobile phase
used  for  the  separation  of  methylhistamine  was
0.05M  NH4H2PO4 (pH  3.0)  containing  2 mM  of
sodium  octanesulfonate.  The  new  assay  technique
could detect methylhistamine as an enzyme activity
product  of  histamine-N-methyltransferase  in  the
brain  and  kidney  of  rats.  Chloropheniramine  mal-
eate,  an  antihistamine,  activated  the  histamine-
N-methyltransferase.  Whether  neurotransmitter  or
neuromodulator, the  role  of histamine in the brain
has not yet been made clear. Therefore, the present
method could be applicable for the enzymatic inves-
tigation of histamine metabolism in central nervous
system or inflammatory reactions.
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Introduction
Histamine-N-methyltransferase (EC 2.1.1.8) is shown
to  be  a  histamine-metabolizing  enzyme  with  dia-
mine  oxidase  (histaminase).1,2 Histamine-N-methyl-
transferase  can  catalyze  the  methylation  of  hista-
mine  to  methylhistamine  in  the  presence  of
S-adenosylmethionine.
The  histamine-N-methyltransferase  activity  is
measured  by  the  isotope  method,3 or  by  fluoro-
metric  detection  using  an  o-phthalaldehyde  com-
plex  with  methylhistamine  and  high-performance
liquid  chromatography  (HPLC)  equipped  with  a
fluorometric  detector.4,5 The  isotope  method  is
highly  sensitive  and  specific  but  the  method  is
expensive  to  operate.  On  the  contrary,  the  HPLC
fluorometric  detection  technique  is  less  sensitive
because  the  fluorescence  intensity  of  methylhista-
mine is lower than that of histamine. Correcting the
disadvantage,  Granerus  and  Wass6 managed  to
detect methylhistamine at less than 1ng/ml (0.1ng/
injection)  by  improvement  of  the  analysis  system.
In these procedures,4–6 however, it is necessary for
methylhistamine  to  be  derivatized  using
o-phthaldialdehyde (OPA) and the procedure is very
complicated.
So far, the present authors have investigated rapid
and specific assays of various enzymatic activities on
HPLC.7 In the present study, a rapid, simple and low-
cost  assay  method  of  histamine-N-methyltransferase
activity has been developed. Therefore, methylhista-
mine separated from the enzymatic reaction system
on  reversed-phase HPLC was  detected and  assayed
spectrophotometrically  at  226nm.  The  new  assay
method also was applicable for the determination of
histamine-N-methyltransferase  activity  in  the  brain
and kidney of rats.
Materials and methods
Reagents and systems
All  chemicals  were  of  analytical  grade  or  reagent
grade, and were obtained from Sigma Chem. Co. (St.
Louis,  MO,  USA)  and  from Wako  Pure  Chem.  Co.
(Tokyo, Japan). The HPLC column used was filled with
Nucleosil-phenyl (7 m m, 4.0 ´ 200mm) from SENSYU
SCIENTIFIC Co. (Tokyo, Japan). The Extrelute-1 of the
extraction tube was obtained from Cica-Merck (Kanto
Kagaku Co., Tokyo, Japan) and the HPLC system used
a SSC-3110 (SENSYU SCIENTIFIC Co., Tokyo, Japan).
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Optimal conditions for
histamine-N-methyltransferase assay
Methylhistamine  produced after  enzymatic  reaction
was  separated  from  histamine  and  S-adenosyl-
methionine as the substrate on HPLC using a reversed-
phase column, Nucleosil-phenyl. Ion-paired chroma-
tography  based  0.05M  NH4H2PO4 (pH  3.0)
containing sodium octanesulfonate was used for the
separation of methylhistamine. The flow rate of the
eluent  was  1.0ml/min  at  ambient  temperature.
Methylhistamine  was  detected  with  an  ultraviolet
(UV) detector at 226nm.
Enzyme source
Histamine-N-methyltransferase  activities  in  rat  brain
and kidney were obtained as follows. The homoge-
nate of excised rat brain and kidney, with five times
the volumes of phosphate-buffered saline (pH 7.4) to
wet weights, was centrifuged at 18,000 ´ g for 20min
at  4°C. The  supernatant  was  used  as  the  enzyme
specimens in the present investigation.
Enzymatic reaction
Incubation  mixture  consisted  of  histamine-
N-methyltransferase specimens (0.6ml of supernatant
in the case of the brain or 0.1ml of supernatant in the
case  of  the  kidney,  and  0.1M  sodium  phosphate
buffer  (pH  7.4)  0.5ml),  0.1ml  of  1 mM
S-adenosylmethionine  and  0.1ml  of  0.25 mM  hista-
mine. The reaction mixture was incubated for 60min
at 37°C and then stopped with 0.2ml of 2.5M sodium
hydroxide.
Extraction of methylhistamine
Methylhistamine was extracted from the incubation
mixture with the following procedure. The reaction
mixture that was made up to 1ml in total with 2.5M
sodium  hydroxide was  adsorbed on  Extrelute-1  for
5min  at  ambient  temperature.  Methylhistamine,  as
the product of enzyme reaction charged on Extrelute-
1, was eluted with various organic solvents to extract
selectively. The solvent of the elute containing methyl-
histamine was removed to dryness, and the residue
was  resuspended  in  the  mobile  phase  and  HPLC
separation and determination were performed.
Correlation between the isotope method and the
HPLC-UV method
The  isotopic  assay  was  performed  following  the
method reported by Beaven and Horakova.3
Results and discussion
Separation of methylhistamine from the
substrates on HPLC
Methylhistamine,  histamine  and  S-adenosyl-
methionine were separated on reversed-phase HPLC
column  0.05M  NH4H2PO4 (pH  3.0)  containing
sodium  octanesulfonate  of  various  concentrations.
Methylhistamine and histamine were not sufficiently
retained  on  Nucleosil-phenyl  column  when  the
mobile  phase  was  composed  only  of  0.05M
NH4H2PO4 (pH 3.0). Therefore, sodium octanesulfo-
nate was added to the mobile phase as the counter
ion.  It  was  found  that  0.05M  NH4H2PO4 (pH  3.0)
containing 2 mM of sodium octanesulfonate was the
best solvent for the present purpose.
Detection of methylhistamine after the
separation on HPLC
The  spectral  absorption  maximum  of  methylhista-
mine  and  histamine  is  at  OD  226nm  and  can  be
detected by a UV detector. Therefore, for the present
purpose of quantitative detection of methylhistamine
after separation on HPLC, UV 226nm was found to be
satisfactory.
Calibration of methylhistamine levels by HPLC
Using the HPLC conditions already described, a linear
calibration  for  methylhistamine  was  obtained  from
0.6 to 10.0ng/injection using 0.001AUFS of detection
range.  The  detection  limit  was  0.6ng/injection
(4.8pmol/injection)  as  methylhistamine  and  was
comparable  with  the  HPLC  fluorometry  method
reported  by  Tsuruta  et  al.4 Fukuda  et  al.5 also
reported that the detection limit of methylhistamine/
OPA derivatives was 50pmol (6.25ng) per injection.
Furthermore, Granerus and Wass6 developed a more
sensitive  procedure  for  methylhistamine  detection,
but  the  detection  limit  was  approximately  0.1ng/
injection nevertheless. Generally, histamine/OPA der-
ivatives  have  stronger  fluorescence  intensity  (>
1000-fold)  than  methylhistamine/OPA  ones.  It  is
thought this is due to the structures.
Optimum conditions for the
histamine-N-methyltransferase activity assay
The  incubation  conditions  for  the  histamine-
N-methyltransferase were performed according to the
method  described  by  Beaven  and  Horakova3 and
Tsuruta et al.4 The enzymatic reaction was linear up
to 120min  of  incubation. Therefore, the conditions
for histamine-N-methyltransferase activity determina-
tion  of  the  HPLC-UV  method  were  the  following:
0.1–0.6ml  of  specimens,  0.1ml  of  1 mM
H. Inoue et al.
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mine were mixed and adjusted to 0.8ml with 0.1M
sodium phosphate buffer (pH 7.4). The mixture was
incubated for 120min at 37°C and then terminated
with 0.2ml of 2.5M sodium hydroxide. The methyl-
histamine,  which  was  the  reaction  product,  was
purified from the substrate.
Correlation between the present technique and
enzyme isotopic assay
The  methylhistamine peak on  the  HPLC chromato-
gram increased with incubation time of these enzyme
mixture at 37°C. The peak, which was suggested to be
methylhistamine, was identified by the retention time
as well as mass spectrometry spectrum analysis of the
elute fraction. The correlation between the HPLC-UV
method and the isotope method was satisfactory (r =
0.912; p < 0.01).
Extraction of methylhistamine with Extrelute-1
The recovery of methylhistamine by Extrelute-1 was
determined using various organic solvents; 59.1% of
the best recovery was obtained using chloroform. The
chloroform  layer  containing  methylhistamine  was
evaporated to  dryness  or  re-extracted with  a  small
portions of 0.1N HCl. The former method needs the
concentration of the chloroform layer but no inter-
fering peaks did appear, and the time required for one
run was less than 10min. The latter method did not
alter the recovery of methylhistamine, but gave many
interfering peaks on the HPLC chromatogram, and the
elution of all peaks required more than 20min. It was
found that the combination of Extrelute-1 and chloro-
form extraction was the best procedure for methylhis-
tamine detection in the incubation mixture.
Beaven and Horakova3 washed the chloroform layer
with alkaline solution to decrease the blank levels, or
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FIG. 1. Typical chromatogram of methylhistamine (upper part) and histamine-N-methyltransferase activity in rat brain and
kidney (lower part). Upper part: (A) substrate blank, (B) standard of methlyhistamine, and (C) rat kidney. Lower part: enzyme
activity on the vertical axis shows histamine-N-methyltransferase activity asnmol/h/mg protein. Each column represents the
mean ± SD. extracted methylhistamine with toluene/iso-amylalco-
hol = 1/1. Tayler and Snyder8 separated methylhista-
mine from the incubation mixture by paper chroma-
tography. The  present  method,  however,  separated
methylhistamine in the chloroform extracts on HPLC
and then detected it at OD 226nm. The blank levels
did not increase as in the case of the isotope method.
Conditions  for  evaporating  the  chloroform  layer
containing methylhistamine were examined by three
methods.  Recovery  of  methylhistamine  was  59.1%
when chloroform was removed under reduced pres-
sure, it was 42.6% by overnight standing at ambient
temperature,  and was  33.3%  by  removal of  chloro-
form on a heating block at 60°C. The coefficients of
variation were ±10.2, ±10.2 and ±12.3%, respectively.
Using chloroform, Extrelute-1 and chloroform drying
under  reduced  pressure  was  found  to  be  the  best
procedure for methylhistamine extraction.
Application of the method for detection of
histamine-N-methyltransferase activity in
biological specimens
Content of histamine-N-methyltransferase in
biological specimens
The present method was used for the measurement of
histamine-N-methyltransferase  activity  in  the  kidney
and  brain  of  rats.  The  typical  chromatograms  are
shown  in  Fig.  1.  The  levels  of  histamine-
N-methyltransferase  activity  could  be  specifically
determined, as  shown  in  Fig.  2. The  data obtained
were the same as the levels reported by Tayler and
Snyder8 or Brown et al.9
Influence of antihistamines on
histamine-N-methyltransferase activity
The  histamine-N-methyltransferase  activity  was  acti-
vated  by  various  concentrations  of  chlorophenyla-
mine  maleate, an  antihistamine. The  stimulation  of
histamine-N-methyltransferase activity was dependent
on the molecular ratio between histamine and anti-
histamine. Tayler and Snyder and other authors10–12
have  also  reported  similar  results.  The  histamine-
N-methyltransferase activity in rat kidney and brain,
and its activation by an antihistamine, is shown in Fig.
2. It is known that administration of antihistamines
induces central nervous system (CNS) depression in
an early stage but the CNS depression is recovered
with routinely administration. The tolerance of CNS
depression  with  continuous  administration  of  anti-
histamines  may  be  caused  by  activation  and/or
induction  of  histamine-N-methyltransferase  in  the
brain.  New  antihistamines  that  suppress  CNS
depression  may  influence  not  only  BBB  function,
but  may  also  enzymatic  activity  of  histamine-
N-methyltransferase.  Whether  neurotransmitter  or
neuromodulator, the role of histamine in the brain has
not  yet  been  made  clear.  Therefore,  the  present
method may be useful for the enzymatic investigation
of histamine metabolism.
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